Grufity logo
Grufity logo

Latest Logos Global Management LP Stock Portfolio

$2.00Billion | No. of Holdings #63

Logos Global Management LP Performance

2026 Q1+13.02%
YTD+13.02%
2025+32.36%

About Logos Global Management LP and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Logos Global Management LP reported an equity portfolio of $2 Billions as of 31 Mar, 2026. <br><br> The top stock holdings of Logos Global Management LP are RVMD, ERAS, IDYA. The fund has invested 9.7% of it's portfolio in REVOLUTION MEDICINES INC and 9% of portfolio in ERASCA INC. <br><br> The fund managers got completely rid off CIDARA THERAPEUTICS INC (CDTX), AVIDITY BIOSCIENCES INC (RNA) and JAZZ PHARMACEUTICALS PLC (JAZZ) stocks. They significantly reduced their stock positions in VAXCYTE INC (PCVX), VERASTEM INC (VSTM) and IBIO INC (IBIO). Logos Global Management LP opened new stock positions in UNITED THERAPEUTICS CORP DEL (UTHR), MADRIGAL PHARMACEUTICALS INC (MDGL) and XENON PHARMACEUTICALS INC (XENE). The fund showed a lot of confidence in some stocks as they added substantially to CENTESSA PHARMACEUTICALS PLC (CNTA), VOR BIOPHARMA INC (VOR) and TYRA BIOSCIENCES INC (TYRA).
Logos Global Management LP Equity Portfolio Value
Last Reported on: 15 May, 2026
$2.00Billion
  as of May 15, 2026

Logos Global Management LP Annual Return Estimates Vs S&P 500

Our best estimate is that Logos Global Management LP made a return of 13.02% in the last quarter. In trailing 12 months, it's portfolio return was 87.36%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
united therapeutics corp del47,438,400
madrigal pharmaceuticals inc44,495,000
xenon pharmaceuticals inc26,167,500
arcus biosciences inc25,920,000
alkermes plc12,376,000
tenax therapeutics inc9,993,750
arrivent biopharma inc8,074,500
relay therapeutics inc7,462,500
New stocks bought by Logos Global Management LP

Additions

Ticker% Inc.
centessa pharmaceuticals plc962
vor biopharma inc650
tyra biosciences inc304
cytokinetics inc191
cg oncology inc187
compass therapeutics inc173
rhythm pharmaceuticals inc136
oric pharmaceuticals inc111
Additions to existing portfolio by Logos Global Management LP

Reductions

Ticker% Reduced
vaxcyte inc-53.85
verastem inc-41.18
ibio inc-35.00
pharvaris n v-35.00
tango therapeutics inc-28.57
amylyx pharmaceuticals inc-26.32
praxis precision medicines i-24.00
lb pharmaceuticals inc-23.75
Logos Global Management LP reduced stake in above stock

Sold off

Ticker$ Sold
mereo biopharma group plc-770,895
uniqure nv-16,152,800
nurix therapeutics inc-9,485,000
avidity biosciences inc-36,065,000
kiniksa pharmaceuticals intl-14,437,500
cidara therapeutics inc-68,475,900
day one biopharmaceuticals i-2,796,000
jazz pharmaceuticals plc-34,000,000
Logos Global Management LP got rid off the above stocks

Sector Distribution

Logos Global Management LP has about 80.7% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare80.7
Others19.3

Market Cap. Distribution

Logos Global Management LP has about 16.6% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
  • LARGE-CAP
  • MICRO-CAP
  • NANO-CAP
Category%
MID-CAP42.5
UNALLOCATED19.3
SMALL-CAP18.2
LARGE-CAP16.6
MICRO-CAP2.3
NANO-CAP1.2

Stocks belong to which Index?

About 62.6% of the stocks held by Logos Global Management LP either belong to S&P 500 or RUSSELL 2000 index.

  • RUSSELL 2000
  • Others
  • S&P 500
Index%
RUSSELL 200060.7
Others37.4
S&P 5001.9
Top 5 Winners (%)%
ERAS
erasca inc
311.1 %
TNGX
tango therapeutics inc
116.7 %
enliven therapeutics inc
97.9 %
CRVS
corvus pharmaceuticals inc
85.5 %
dianthus therapeutics inc
83.4 %
Top 5 Winners ($)$
ERAS
erasca inc
150.5 M
TNGX
tango therapeutics inc
43.4 M
RVMD
revolution medicines inc
35.2 M
CNTA
centessa pharmaceuticals plc
17.1 M
dianthus therapeutics inc
15.3 M
Top 5 Losers (%)%
fractyl health inc
-75.6 %
OLMA
olema pharmaceuticals inc
-40.4 %
OCUL
ocular therapeutix inc
-29.3 %
structure therapeutics inc
-28.1 %
maze therapeutics inc
-25.6 %
Top 5 Losers ($)$
OLMA
olema pharmaceuticals inc
-32.4 M
OCUL
ocular therapeutix inc
-13.5 M
maze therapeutics inc
-12.7 M
abivax sa
-12.6 M
structure therapeutics inc
-11.7 M

Logos Global Management LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Logos Global Management LP

Logos Global Management LP has 63 stocks in it's portfolio. About 49.4% of the portfolio is in top 10 stocks. OLMA proved to be the most loss making stock for the portfolio. ERAS was the most profitable stock for Logos Global Management LP last quarter.

$1.94BTotal Value
76.00Positions
15 May, 2026Last Reported
Current holdings of Current Stock Holdings of Logos Global Management LP, last reported on 15 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
DBVT
Dbv Technologies S A

Dbv Technologies S A

DBVT
Logos Global Management LP's holding in Dbv Technologies S A over time
0%0.00
$0.00
0%
decreased 100 percentsold off